首页 > 最新文献

Journal of Applied Clinical Medical Physics最新文献

英文 中文
Comprehensive clinical evaluation of novel 4DCT-based lung function imaging methods. 基于4dct的新型肺功能成像方法的综合临床评价。
IF 2 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-08 DOI: 10.1002/acm2.70088
Ehsan Golkar, Taindra Neupane, Lydia Wilson, Jennifer Kwak, Richard Castillo, Edward Castillo, Yevgeniy Vinogradskiy

Purpose: Methods have been developed that apply image processing to 4DCTs to generate 4DCT-ventilation/perfusion lung imaging. Traditional methods for 4DCT-ventilation rely on Hounsfield-Unit (HU) density-change methods and suffer from poor numerical robustness while not providing 4DCT-perfusion data. The purpose of this work was to evaluate the clinical differences between classic HU-based 4DCT-ventilation approaches and novel 4DCT-ventilation/perfusion approaches.

Methods: Data from 63 lung cancer patients enrolled in a functional avoidance clinical trial were analyzed. 4DCT-data were used to generate four lung-function images: (1) classical HU-based 4DCT-ventilation ("4DCT-vent-HU"), and three novel, statistically robust methods: (2) 4DCT-ventilation based on the Mass Conserving Volume Change ("4DCT-vent-MCVC"), (3) 4DCT-ventilation using the Integrated Jacobian Formulation, and (4) 4DCT-perfusion. A radiologist reviewed all images for ventilation/perfusion defects (scored as yes/no) and the scores for the novel approaches were compared to those of 4DCT-vent-HU using receiver operating characteristic (ROC) analysis. Functional contours were generated using thresholding methods, and the contours from the three novel 4DCT-ventilation methods were compared against that from 4DCT-vent-HU (Dice similarity coefficients [DSC]). Functional mean lung dose (fMLD) and dose-function metrics were compared against dose-function metrics using 4DCT-vent-HU.

Results: ROC analysis revealed accuracy in the range of 0.55 to 0.73 comparing radiologist interpretations of 4DCT-vent-HU against the three novel approaches. Average DSC values were 0.41 ± 0.19, 0.44 ± 0.16, and 0.42 ± 0.17 comparing 4DCT-vent-HU to 4DCT-vent-IJF, 4DCT-vent-MCVC, and 4DCT-perf, respectively. All novel imaging methods showed significant differences (p < 0.01) in dose-function metrics compared to those of 4DCT-vent-HU. 4DCT-vent-MCVC and 4DCT-Perf depicted the smallest and largest differences from 4DCT-vent-HU in fMLD (3.51 ± 3.20 Gy and 5.90 ± 5.29 Gy, respectively).

Conclusion: This is the first work to comprehensively compare novel 4DCT-ventilation/perfusion methods against classical formulations. Our data show that significant differences between the 4DCT-based functional imaging methods exist, suggesting that studies are needed to evaluate which methods provide the most robust clinical results.

目的:已开发出将图像处理应用于 4DCT 以生成 4DCT 通气/灌注肺成像的方法。传统的 4DCT 通气方法依赖于 Hounsfield 单位(HU)密度变化方法,其数值稳健性较差,同时无法提供 4DCT 灌注数据。这项工作的目的是评估基于 HU 的经典 4DCT 通气方法与新型 4DCT 通气/灌注方法之间的临床差异:方法:分析了参加功能性回避临床试验的 63 名肺癌患者的数据。4DCT数据被用于生成四种肺功能图像:(1)经典的基于HU的4DCT-通气("4DCT-vent-HU"),以及三种新型的、统计学上稳健的方法:(2)基于质量保证容积变化的4DCT-通气("4DCT-vent-MCVC"),(3)使用综合雅各布公式的4DCT-通气,以及(4)4DCT-灌注。放射科医生对所有图像进行通气/灌注缺陷检查(按是/否评分),并使用接收器操作特征(ROC)分析将新方法的评分与 4DCT-vent-HU 的评分进行比较。使用阈值法生成功能轮廓,并将三种新型 4DCT 通气法的轮廓与 4DCT 通气法的轮廓进行比较(Dice 相似系数 [DSC])。将功能性平均肺剂量(fMLD)和剂量功能指标与使用 4DCT-vent-HU 的剂量功能指标进行了比较:ROC分析显示,放射科医生对4DCT-vent-HU的解释与三种新方法相比,准确度在0.55至0.73之间。4DCT-vent-HU与4DCT-vent-IJF、4DCT-vent-MCVC和4DCT-perf的平均DSC值分别为0.41±0.19、0.44±0.16和0.42±0.17。所有新型成像方法均显示出显著差异(P这是第一项全面比较新型 4DCT 通气/灌注方法与经典配方的研究。我们的数据显示,基于 4DCT 的功能成像方法之间存在显著差异,这表明需要进行研究以评估哪种方法能提供最可靠的临床结果。
{"title":"Comprehensive clinical evaluation of novel 4DCT-based lung function imaging methods.","authors":"Ehsan Golkar, Taindra Neupane, Lydia Wilson, Jennifer Kwak, Richard Castillo, Edward Castillo, Yevgeniy Vinogradskiy","doi":"10.1002/acm2.70088","DOIUrl":"https://doi.org/10.1002/acm2.70088","url":null,"abstract":"<p><strong>Purpose: </strong>Methods have been developed that apply image processing to 4DCTs to generate 4DCT-ventilation/perfusion lung imaging. Traditional methods for 4DCT-ventilation rely on Hounsfield-Unit (HU) density-change methods and suffer from poor numerical robustness while not providing 4DCT-perfusion data. The purpose of this work was to evaluate the clinical differences between classic HU-based 4DCT-ventilation approaches and novel 4DCT-ventilation/perfusion approaches.</p><p><strong>Methods: </strong>Data from 63 lung cancer patients enrolled in a functional avoidance clinical trial were analyzed. 4DCT-data were used to generate four lung-function images: (1) classical HU-based 4DCT-ventilation (\"4DCT-vent-HU\"), and three novel, statistically robust methods: (2) 4DCT-ventilation based on the Mass Conserving Volume Change (\"4DCT-vent-MCVC\"), (3) 4DCT-ventilation using the Integrated Jacobian Formulation, and (4) 4DCT-perfusion. A radiologist reviewed all images for ventilation/perfusion defects (scored as yes/no) and the scores for the novel approaches were compared to those of 4DCT-vent-HU using receiver operating characteristic (ROC) analysis. Functional contours were generated using thresholding methods, and the contours from the three novel 4DCT-ventilation methods were compared against that from 4DCT-vent-HU (Dice similarity coefficients [DSC]). Functional mean lung dose (fMLD) and dose-function metrics were compared against dose-function metrics using 4DCT-vent-HU.</p><p><strong>Results: </strong>ROC analysis revealed accuracy in the range of 0.55 to 0.73 comparing radiologist interpretations of 4DCT-vent-HU against the three novel approaches. Average DSC values were 0.41 ± 0.19, 0.44 ± 0.16, and 0.42 ± 0.17 comparing 4DCT-vent-HU to 4DCT-vent-IJF, 4DCT-vent-MCVC, and 4DCT-perf, respectively. All novel imaging methods showed significant differences (p < 0.01) in dose-function metrics compared to those of 4DCT-vent-HU. 4DCT-vent-MCVC and 4DCT-Perf depicted the smallest and largest differences from 4DCT-vent-HU in fMLD (3.51 ± 3.20 Gy and 5.90 ± 5.29 Gy, respectively).</p><p><strong>Conclusion: </strong>This is the first work to comprehensively compare novel 4DCT-ventilation/perfusion methods against classical formulations. Our data show that significant differences between the 4DCT-based functional imaging methods exist, suggesting that studies are needed to evaluate which methods provide the most robust clinical results.</p>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":" ","pages":"e70088"},"PeriodicalIF":2.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143811410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Log file-based quality assurance method for respiratory gating system. 基于日志文件的呼吸门控系统质量保证方法。
IF 2 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-08 DOI: 10.1002/acm2.70101
Wonjoong Cheon, Young Kyu Lee, Yunji Seol, Chan-Beom Park, Hong Qi Tan, Kyu Hye Choi, Young-Nam Kang, Byung Ock Choi

Background: As medical linear accelerator technology advances, enabling higher dose rate deliveries, hypofractionation regimens has increased. This necessitates respiratory gating systems that synchronize radiation delivery with tumor position, requiring simple rigorous quality assurance (QA) to ensure treatment accuracy and patient safety.

Purpose: This study aimed to propose log-based QA for respiratory-gated radiation therapy using the respiratory gating system and treatment machine.

Methods: 4D CT scans were performed with a Varian motion phantom using a Varian Respiratory Gating for Scanner (RGSC). A treatment plan using 25%-75% respiratory phases with 100 MU was created and delivered to a solid water phantom. Treatment logs containing respiratory signals, beam on/off flags, and frame information were extracted from the treatment planning system's offline review. Log file analyses were conducted using in-house softwares to assess temporal synchronization between respiratory phases and beam triggers. Output measurements using a calibrated ion chamber (FC65G) were performed to evaluate dosimetric accuracy. Additionally, EPID images were acquired in cine mode and analyzed frame-by-frame to independently verify beam delivery timing.

Results: Log file analysis revealed precise temporal synchronization, with mean time differences of 0.03 s ± 0.05 s between the planned 25% phase and beam-on, and -0.04 s ± 0.05 s between 75% phase and beam-off. The log-derived beam-on duration (2.61 s ± 0.02 s) closely matched the planned duration (2.66 s ± 0.00 s). Three-month log data showed consistent temporal accuracy, with trigger-on times remaining stable at 2.60 s ± 0.01 s across all measurements. Supporting ion chamber measurements confirmed dosimetric agreement between gating and non-gating modes (difference: 0.05 cGy ± 0.09 cGy) CONCLUSIONS: The proposed log file-based QA method demonstrated high accuracy and reproducibility in assessing respiratory gating performance. This approach provides an efficient, objective method for standardizing QA procedures in respiratory-gated radiation therapy, enhancing treatment accuracy and patient safety.

背景:随着医学直线加速器技术的进步,使更高剂量率的递送成为可能,低分割方案有所增加。这就需要呼吸门控系统,使放射传输与肿瘤位置同步,需要简单严格的质量保证(QA)来确保治疗的准确性和患者的安全。目的:本研究旨在利用呼吸门控系统和治疗机为呼吸门控放射治疗提供基于日志的质量保证。方法:使用瓦里安呼吸门控扫描仪(RGSC)对患者进行4D CT扫描。采用25%-75%的呼吸相和100 MU的治疗方案,并将其传递给固体水模体。治疗日志包含呼吸信号、波束开/关标志和帧信息,从治疗计划系统的离线审查中提取。使用内部软件进行日志文件分析,以评估呼吸期和波束触发之间的时间同步。使用校准的离子室(FC65G)进行输出测量,以评估剂量学的准确性。此外,在电影模式下获取EPID图像并逐帧分析以独立验证光束传输时间。结果:日志文件分析显示了精确的时间同步,计划的25%相位与波束的平均时差为0.03 s±0.05 s, 75%相位与波束的平均时差为-0.04 s±0.05 s。log-derived波束的持续时间(2.61 s±0.02 s)与计划的持续时间(2.66 s±0.00 s)非常接近。三个月的log数据显示了一致的时间准确性,在所有测量中,触发时间保持稳定在2.60 s±0.01 s。支持离子室测量证实了门控和非门控模式之间的剂量学一致性(差异:0.05 cGy±0.09 cGy)结论:所提出的基于日志文件的QA方法在评估呼吸门控性能方面具有较高的准确性和重复性。该方法为标准化呼吸门控放射治疗的质量保证程序,提高治疗准确性和患者安全性提供了一种高效、客观的方法。
{"title":"Log file-based quality assurance method for respiratory gating system.","authors":"Wonjoong Cheon, Young Kyu Lee, Yunji Seol, Chan-Beom Park, Hong Qi Tan, Kyu Hye Choi, Young-Nam Kang, Byung Ock Choi","doi":"10.1002/acm2.70101","DOIUrl":"https://doi.org/10.1002/acm2.70101","url":null,"abstract":"<p><strong>Background: </strong>As medical linear accelerator technology advances, enabling higher dose rate deliveries, hypofractionation regimens has increased. This necessitates respiratory gating systems that synchronize radiation delivery with tumor position, requiring simple rigorous quality assurance (QA) to ensure treatment accuracy and patient safety.</p><p><strong>Purpose: </strong>This study aimed to propose log-based QA for respiratory-gated radiation therapy using the respiratory gating system and treatment machine.</p><p><strong>Methods: </strong>4D CT scans were performed with a Varian motion phantom using a Varian Respiratory Gating for Scanner (RGSC). A treatment plan using 25%-75% respiratory phases with 100 MU was created and delivered to a solid water phantom. Treatment logs containing respiratory signals, beam on/off flags, and frame information were extracted from the treatment planning system's offline review. Log file analyses were conducted using in-house softwares to assess temporal synchronization between respiratory phases and beam triggers. Output measurements using a calibrated ion chamber (FC65G) were performed to evaluate dosimetric accuracy. Additionally, EPID images were acquired in cine mode and analyzed frame-by-frame to independently verify beam delivery timing.</p><p><strong>Results: </strong>Log file analysis revealed precise temporal synchronization, with mean time differences of 0.03 s ± 0.05 s between the planned 25% phase and beam-on, and -0.04 s ± 0.05 s between 75% phase and beam-off. The log-derived beam-on duration (2.61 s ± 0.02 s) closely matched the planned duration (2.66 s ± 0.00 s). Three-month log data showed consistent temporal accuracy, with trigger-on times remaining stable at 2.60 s ± 0.01 s across all measurements. Supporting ion chamber measurements confirmed dosimetric agreement between gating and non-gating modes (difference: 0.05 cGy ± 0.09 cGy) CONCLUSIONS: The proposed log file-based QA method demonstrated high accuracy and reproducibility in assessing respiratory gating performance. This approach provides an efficient, objective method for standardizing QA procedures in respiratory-gated radiation therapy, enhancing treatment accuracy and patient safety.</p>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":" ","pages":"e70101"},"PeriodicalIF":2.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143803294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a generic focal spot measurement method suitable for bore-type linacs. 一种适用于镗孔式直线机的通用焦斑测量方法的开发。
IF 2 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-07 DOI: 10.1002/acm2.70077
Hidetoshi Shimizu, Kazuharu Nishitani, Tomoki Kitagawa, Koji Sasaki, Takahiro Aoyama, Takeshi Kodaira

Purpose: In linear accelerators, deviations in the x-ray focal spot position significantly affect the accuracy of radiation therapy. However, as the focal spot position in bore-type linac systems such as the Radixact system, cannot be assessed using conventional methods, a new evaluation method is required. This study aimed to develop a novel method to measure the focal spot position of Radixact and evaluate any deviations from the ideal x-ray focal spot position.

Methods: A structurally simplified measurement system was developed to evaluate the focal spot position of the Radixact system. This system consisted of a vertically aligned metal bar and an ionization chamber, which was moved stepwise to acquire the beam profiles. The focal spot position deviation was calculated based on the center differences of the profiles obtained from two different upstream and downstream locations of the metal bar.

Results: The measurement results indicated that the focal spot position shift was 0.42 mm and -0.36 mm at the target height in the IEC-X and -Y directions, respectively. The measurement uncertainty was 0.187 mm, confirming a slight deviation from the ideal focal position.

Conclusions: This study developed a novel method to accurately evaluate the x-ray focal spot position of the Radixact system, which can potentially be applied to other conventional linear accelerators and bore-type systems, such as Halcyon, to improve the accuracy of radiotherapy. However, its generalizability and applicability to different radiotherapy machines must be explored further.

目的:在直线加速器中,x线焦斑位置的偏差严重影响放射治疗的准确性。然而,由于径向直线系统(Radixact)等孔型直线系统的焦点光斑位置无法用常规方法进行评估,因此需要一种新的评估方法。本研究旨在建立一种测量Radixact焦斑位置的新方法,并评估其与理想x射线焦斑位置的偏差。方法:开发了一种结构简化的测量系统,用于评估Radixact系统的焦点光斑位置。该系统由一个垂直排列的金属棒和一个电离室组成,电离室逐步移动以获得光束的轮廓。根据从金属棒的上下游两个不同位置获得的轮廓的中心差计算焦点光斑位置偏差。结果:测量结果表明,在IEC-X和-Y方向上,焦斑在目标高度处的位置位移分别为0.42 mm和-0.36 mm。测量不确定度为0.187 mm,与理想焦点位置有轻微偏差。结论:本研究开发了一种新的方法来准确评估Radixact系统的x射线焦斑位置,该方法有可能应用于其他传统的线性加速器和孔型系统,如Halcyon,以提高放疗的准确性。然而,其通用性和对不同放疗机的适用性还有待进一步探讨。
{"title":"Development of a generic focal spot measurement method suitable for bore-type linacs.","authors":"Hidetoshi Shimizu, Kazuharu Nishitani, Tomoki Kitagawa, Koji Sasaki, Takahiro Aoyama, Takeshi Kodaira","doi":"10.1002/acm2.70077","DOIUrl":"https://doi.org/10.1002/acm2.70077","url":null,"abstract":"<p><strong>Purpose: </strong>In linear accelerators, deviations in the x-ray focal spot position significantly affect the accuracy of radiation therapy. However, as the focal spot position in bore-type linac systems such as the Radixact system, cannot be assessed using conventional methods, a new evaluation method is required. This study aimed to develop a novel method to measure the focal spot position of Radixact and evaluate any deviations from the ideal x-ray focal spot position.</p><p><strong>Methods: </strong>A structurally simplified measurement system was developed to evaluate the focal spot position of the Radixact system. This system consisted of a vertically aligned metal bar and an ionization chamber, which was moved stepwise to acquire the beam profiles. The focal spot position deviation was calculated based on the center differences of the profiles obtained from two different upstream and downstream locations of the metal bar.</p><p><strong>Results: </strong>The measurement results indicated that the focal spot position shift was 0.42 mm and -0.36 mm at the target height in the IEC-X and -Y directions, respectively. The measurement uncertainty was 0.187 mm, confirming a slight deviation from the ideal focal position.</p><p><strong>Conclusions: </strong>This study developed a novel method to accurately evaluate the x-ray focal spot position of the Radixact system, which can potentially be applied to other conventional linear accelerators and bore-type systems, such as Halcyon, to improve the accuracy of radiotherapy. However, its generalizability and applicability to different radiotherapy machines must be explored further.</p>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":" ","pages":"e70077"},"PeriodicalIF":2.0,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143803291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Open-source deep-learning models for segmentation of normal structures for prostatic and gynecological high-dose-rate brachytherapy: Comparison of architectures. 用于前列腺和妇科高剂量近距离放射治疗的正常结构分割的开源深度学习模型:架构的比较。
IF 2 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-05 DOI: 10.1002/acm2.70089
Andrew J Krupien, Yasin Abdulkadir, Dishane C Luximon, John Charters, Huiming Dong, Jonathan Pham, Dylan O'Connell, Jack Neylon, James M Lamb

Background: The use of deep learning-based auto-contouring algorithms in various treatment planning services is increasingly common. There is a notable deficit of commercially or publicly available models trained on large or diverse datasets containing high-dose-rate (HDR) brachytherapy treatment scans, leading to poor performance on images that include HDR implants.

Purpose: To implement and evaluate automatic organs-at-risk (OARs) segmentation models for use in prostatic-and-gynecological computed tomography (CT)-guided high-dose-rate brachytherapy treatment planning.

Methods and materials: 1316 computed tomography (CT) scans and corresponding segmentation files from 1105 prostatic-or-gynecological HDR patients treated at our institution from 2017 to 2024 were used for model training. Data sources comprised six CT scanners including a mobile CT unit with previously reported susceptibility to image streaking artifacts. Two UNet-derived model architectures, UNet++ and nnU-Net, were investigated for bladder and rectum model training. The models were tested on 100 CT scans and clinically-used segmentation files from 62 prostatic-or-gynecological HDR brachytherapy patients, disjoint from the training set, collected in 2024. Performance was evaluated using the Dice-Similarity-Coefficient (DSC) between model predicted contours and clinically-used contours on slices in common with the Clinical-Target-Volume (CTV). Additionally, a blinded evaluation of ten random test cases was conducted by three experienced planners.

Results: Median (interquartile range) 3D DSC on CTV-containing slices were 0.95 (0.04) and 0.87 (0.09) for the UNet++ bladder and rectum models, respectively, and 0.96 (0.03) and 0.88 (0.10) for the nnU-Net. The rank-sum test did not reveal statistically significant differences in these DSC (p = 0.15 and 0.27, respectively). The blinded evaluation scored trained models higher than clinically-used contours.

Conclusion: Both UNet-derived architectures perform similarly on the bladder and rectum and are adequately accurate to reduce contouring time in a review-and-edit context during HDR brachytherapy planning. The UNet++ models were chosen for implementation at our institution due to lower computing hardware requirements and are in routine clinical use.

背景:基于深度学习的自动轮廓算法在各种治疗计划服务中的应用越来越普遍。在包含高剂量率(HDR)近距离治疗扫描的大型或多种数据集上训练的商业或公开可用模型存在明显缺陷,导致在包含HDR植入物的图像上表现不佳。目的:实现和评估自动危险器官(OARs)分割模型在前列腺和妇科计算机断层扫描(CT)引导下的高剂量率近距离治疗计划中的应用。方法与材料:选取我院2017 - 2024年收治的1105例前列腺或妇科HDR患者的1316张CT扫描图及相应的分割文件进行模型训练。数据来源包括6台CT扫描仪,其中包括一台移动CT设备,该设备以前报道过对图像条纹伪影的敏感性。研究了两种由UNet衍生的模型架构,UNet++和nnU-Net,用于膀胱和直肠模型训练。这些模型在2024年收集的62例前列腺或妇科HDR近距离治疗患者的100个CT扫描和临床使用的分割文件上进行了测试,这些分割文件与训练集无关。使用模型预测轮廓与临床使用的切片轮廓之间的骰子相似系数(DSC)与临床目标体积(CTV)共同评估性能。另外,由三个经验丰富的计划人员对十个随机测试用例进行盲法评估。结果:UNet++膀胱和直肠模型的ctv切片三维DSC中位数(四分位数范围)分别为0.95(0.04)和0.87 (0.09),nnU-Net模型的三维DSC中位数(四分位数范围)分别为0.96(0.03)和0.88(0.10)。秩和检验未显示这些DSC有统计学显著差异(p分别= 0.15和0.27)。盲法评估对训练模型的评分高于临床使用的轮廓线。结论:两种unet衍生的架构在膀胱和直肠上的表现相似,并且在HDR近距离治疗计划的回顾和编辑背景下足够准确地减少轮廓时间。由于对计算硬件的要求较低,并且在常规临床应用中,我们选择了UNet++模型来实现我们的机构。
{"title":"Open-source deep-learning models for segmentation of normal structures for prostatic and gynecological high-dose-rate brachytherapy: Comparison of architectures.","authors":"Andrew J Krupien, Yasin Abdulkadir, Dishane C Luximon, John Charters, Huiming Dong, Jonathan Pham, Dylan O'Connell, Jack Neylon, James M Lamb","doi":"10.1002/acm2.70089","DOIUrl":"https://doi.org/10.1002/acm2.70089","url":null,"abstract":"<p><strong>Background: </strong>The use of deep learning-based auto-contouring algorithms in various treatment planning services is increasingly common. There is a notable deficit of commercially or publicly available models trained on large or diverse datasets containing high-dose-rate (HDR) brachytherapy treatment scans, leading to poor performance on images that include HDR implants.</p><p><strong>Purpose: </strong>To implement and evaluate automatic organs-at-risk (OARs) segmentation models for use in prostatic-and-gynecological computed tomography (CT)-guided high-dose-rate brachytherapy treatment planning.</p><p><strong>Methods and materials: </strong>1316 computed tomography (CT) scans and corresponding segmentation files from 1105 prostatic-or-gynecological HDR patients treated at our institution from 2017 to 2024 were used for model training. Data sources comprised six CT scanners including a mobile CT unit with previously reported susceptibility to image streaking artifacts. Two UNet-derived model architectures, UNet++ and nnU-Net, were investigated for bladder and rectum model training. The models were tested on 100 CT scans and clinically-used segmentation files from 62 prostatic-or-gynecological HDR brachytherapy patients, disjoint from the training set, collected in 2024. Performance was evaluated using the Dice-Similarity-Coefficient (DSC) between model predicted contours and clinically-used contours on slices in common with the Clinical-Target-Volume (CTV). Additionally, a blinded evaluation of ten random test cases was conducted by three experienced planners.</p><p><strong>Results: </strong>Median (interquartile range) 3D DSC on CTV-containing slices were 0.95 (0.04) and 0.87 (0.09) for the UNet++ bladder and rectum models, respectively, and 0.96 (0.03) and 0.88 (0.10) for the nnU-Net. The rank-sum test did not reveal statistically significant differences in these DSC (p = 0.15 and 0.27, respectively). The blinded evaluation scored trained models higher than clinically-used contours.</p><p><strong>Conclusion: </strong>Both UNet-derived architectures perform similarly on the bladder and rectum and are adequately accurate to reduce contouring time in a review-and-edit context during HDR brachytherapy planning. The UNet++ models were chosen for implementation at our institution due to lower computing hardware requirements and are in routine clinical use.</p>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":" ","pages":"e70089"},"PeriodicalIF":2.0,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143788426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surface dose analysis and dosimetric comparison of Halcyon versus Truebeam in breast cancer radiotherapy: An OSL dosimetry study. Halcyon和Truebeam在乳腺癌放疗中的表面剂量分析和剂量学比较:一项OSL剂量学研究。
IF 2 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-03 DOI: 10.1002/acm2.70085
Mustafa Çağlar, Kudret Akçay, Esra Serin, Dursun Eşitmez, Mehmet Sıddık Cebe, Navid Kheradmand, Ömer Yazıcı, Dilek Ünal, Evrim Metcalfe

Purpose: Breast cancer is a neoplastic disease with high prevalence among women. Radiotherapy is one of the principal treatment modalities for this disease, but it poses significant challenges. This study aimed to compare and evaluate the technical and dosimetric performance of conventional C-arm linac systems and a new design, Halcyon, in the context of breast radiotherapy.

Methods: The study included ten patients who had undergone left breast radiotherapy. Additionally, breast radiotherapy was simulated with an anthropomorphic phantom, and similar planning studies were performed. A total of 40 treatment plans were prepared for ten patients using the field-in-field (FinF) and volumetric modulated arc therapy (VMAT) techniques on both TrueBeam and Halcyon systems. Subsequently, treatment plans were created for anthropomorphic phantoms using both techniques on both devices. The dosimetric comparisons were conducted on treatment plans with different treatment techniques on both devices. An anthropomorphic phantom was employed to ascertain the surface dose during treatment, with irradiation conducted in the following with the OSL dosimetry method.

Results: Patient plan comparisons showed no statistically significant differences in planning target volume (PTV) outcomes between techniques and devices. Upon analysis of the organ at risk (OAR), statistically significant differences were identified for FinF in both devices for low-dose regions. Analysis of the OSL results obtained from phantom irradiations revealed that the Halcyon results were higher than those obtained with the TrueBeam for both techniques. Additionally, a comparison of OSL results with the TPS data revealed discrepancies of up to 18% within the field and up to 22% outside the field. Furthermore, Halcyon demonstrated higher Monitor Unit (MU) values for both techniques, while still maintaining shorter treatment times.

Conclusion: The Halcyon demonstrated comparable technical and dosimetric outcomes to conventional C-arm linac in breast radiotherapy. Its distinctive design features contribute to the implementation of efficient and secure treatment modalities.

目的:乳腺癌是一种女性高发的肿瘤性疾病。放疗是治疗这种疾病的主要方法之一,但它也带来了巨大的挑战。本研究旨在比较和评估传统 C 臂直列加速器系统和新型设计 Halcyon 在乳腺放射治疗方面的技术和剂量性能:研究对象包括十名接受过左侧乳房放射治疗的患者。此外,还使用拟人化模型模拟了乳腺放射治疗,并进行了类似的计划研究。在 TrueBeam 和 Halcyon 系统上使用场中场(FinF)和容积调制弧治疗(VMAT)技术为十名患者准备了共 40 个治疗计划。随后,在两种设备上使用这两种技术为拟人化模型创建了治疗计划。对两种设备上采用不同治疗技术的治疗计划进行了剂量比较。使用拟人模型确定治疗过程中的表面剂量,然后使用 OSL 剂量测定法进行照射:患者计划比较显示,不同技术和设备的计划靶体积(PTV)结果在统计学上没有显著差异。对危险器官(OAR)进行分析后发现,两种设备在低剂量区域的 FinF 方面存在统计学意义上的显著差异。对从模型照射中获得的 OSL 结果进行分析后发现,Halcyon 的结果高于 TrueBeam 两种技术的结果。此外,将 OSL 结果与 TPS 数据进行比较后发现,场内差异高达 18%,场外差异高达 22%。此外,Halcyon 对两种技术都显示出更高的监控单元 (MU) 值,同时仍保持较短的治疗时间:结论:在乳腺放射治疗中,Halcyon 的技术和剂量结果与传统的 C 臂直列加速器相当。其独特的设计特点有助于实施高效、安全的治疗模式。
{"title":"Surface dose analysis and dosimetric comparison of Halcyon versus Truebeam in breast cancer radiotherapy: An OSL dosimetry study.","authors":"Mustafa Çağlar, Kudret Akçay, Esra Serin, Dursun Eşitmez, Mehmet Sıddık Cebe, Navid Kheradmand, Ömer Yazıcı, Dilek Ünal, Evrim Metcalfe","doi":"10.1002/acm2.70085","DOIUrl":"https://doi.org/10.1002/acm2.70085","url":null,"abstract":"<p><strong>Purpose: </strong>Breast cancer is a neoplastic disease with high prevalence among women. Radiotherapy is one of the principal treatment modalities for this disease, but it poses significant challenges. This study aimed to compare and evaluate the technical and dosimetric performance of conventional C-arm linac systems and a new design, Halcyon, in the context of breast radiotherapy.</p><p><strong>Methods: </strong>The study included ten patients who had undergone left breast radiotherapy. Additionally, breast radiotherapy was simulated with an anthropomorphic phantom, and similar planning studies were performed. A total of 40 treatment plans were prepared for ten patients using the field-in-field (FinF) and volumetric modulated arc therapy (VMAT) techniques on both TrueBeam and Halcyon systems. Subsequently, treatment plans were created for anthropomorphic phantoms using both techniques on both devices. The dosimetric comparisons were conducted on treatment plans with different treatment techniques on both devices. An anthropomorphic phantom was employed to ascertain the surface dose during treatment, with irradiation conducted in the following with the OSL dosimetry method.</p><p><strong>Results: </strong>Patient plan comparisons showed no statistically significant differences in planning target volume (PTV) outcomes between techniques and devices. Upon analysis of the organ at risk (OAR), statistically significant differences were identified for FinF in both devices for low-dose regions. Analysis of the OSL results obtained from phantom irradiations revealed that the Halcyon results were higher than those obtained with the TrueBeam for both techniques. Additionally, a comparison of OSL results with the TPS data revealed discrepancies of up to 18% within the field and up to 22% outside the field. Furthermore, Halcyon demonstrated higher Monitor Unit (MU) values for both techniques, while still maintaining shorter treatment times.</p><p><strong>Conclusion: </strong>The Halcyon demonstrated comparable technical and dosimetric outcomes to conventional C-arm linac in breast radiotherapy. Its distinctive design features contribute to the implementation of efficient and secure treatment modalities.</p>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":" ","pages":"e70085"},"PeriodicalIF":2.0,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143779899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of a medical physics educational program for science teachers. 科学教师医学物理教育课程评估。
IF 2 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-03 DOI: 10.1002/acm2.70087
Ashley J Cetnar, Jeffrey Woollard, Lin Ding

Introduction: Medical physics is a fulfilling profession where physics is applied to advance human health. However, many are uninformed of the role of physicists in medicine, and students are unaware of this career pathway. This study presents a pilot 1-year program for science teachers to learn about physics in medicine and share with students and teachers.

Methods: A cohort of middle school and high school science teachers were selected to learn about physics in medicine, develop lesson plans for their students, participate in a Physics in Medicine field trip hosted at a cancer hospital, and concluded with a professional development day for other regional science teachers. Surveys were conducted throughout the program to assess attitudes toward teaching medical physics, content knowledge of medical physics, collaboration, and demographic information from participants.

Results: The program was implemented over the course of a year which included 5 school districts, 10 science teachers, and hundreds of students. After participating in the program, teacher scores on surveys regarding attitudes toward teaching medical physics and content knowledge significantly increased for the cohort. Strong collaboration between teaching pairs was maintained throughout the program based on survey responses. Teachers participating in the 1-day professional development program also benefited from the program based on survey responses regarding attitudes toward medical physics and interest in learning more about medical physics.

Discussion: This pilot study demonstrated the feasibility and effectiveness of an educational model for teachers' understanding and connecting medical physics with students in their schools.  The program was well received by teachers and students, and this manuscript provides guidelines for effective replication of the curriculum at other institutions.

简介医学物理学是一门应用物理学促进人类健康的充实职业。然而,许多人并不了解物理学家在医学中的作用,学生也不了解这一职业途径。本研究提出了一个为期一年的试点项目,让科学教师了解医学物理,并与学生和教师分享:方法:选拔了一批初中和高中理科教师,让他们学习医学物理知识,为学生制定课程计划,参加在一家癌症医院举办的医学物理实地考察,最后在专业发展日为其他地区的理科教师举办讲座。在整个项目过程中都进行了调查,以评估参与者对医学物理教学的态度、医学物理内容知识、合作以及人口统计学信息:该计划实施了一年,涉及 5 个学区、10 名科学教师和数百名学生。参加该计划后,教师对医学物理教学态度和内容知识的调查得分明显提高。根据调查反馈,在整个项目期间,教学对子之间保持了紧密的合作。参加为期 1 天的专业发展项目的教师也从该项目中受益匪浅:这项试点研究证明了教师了解医学物理并将其与学校学生联系起来的教育模式的可行性和有效性。 该项目受到了教师和学生的欢迎,本手稿为在其他机构有效推广该课程提供了指导。
{"title":"Assessment of a medical physics educational program for science teachers.","authors":"Ashley J Cetnar, Jeffrey Woollard, Lin Ding","doi":"10.1002/acm2.70087","DOIUrl":"https://doi.org/10.1002/acm2.70087","url":null,"abstract":"<p><strong>Introduction: </strong>Medical physics is a fulfilling profession where physics is applied to advance human health. However, many are uninformed of the role of physicists in medicine, and students are unaware of this career pathway. This study presents a pilot 1-year program for science teachers to learn about physics in medicine and share with students and teachers.</p><p><strong>Methods: </strong>A cohort of middle school and high school science teachers were selected to learn about physics in medicine, develop lesson plans for their students, participate in a Physics in Medicine field trip hosted at a cancer hospital, and concluded with a professional development day for other regional science teachers. Surveys were conducted throughout the program to assess attitudes toward teaching medical physics, content knowledge of medical physics, collaboration, and demographic information from participants.</p><p><strong>Results: </strong>The program was implemented over the course of a year which included 5 school districts, 10 science teachers, and hundreds of students. After participating in the program, teacher scores on surveys regarding attitudes toward teaching medical physics and content knowledge significantly increased for the cohort. Strong collaboration between teaching pairs was maintained throughout the program based on survey responses. Teachers participating in the 1-day professional development program also benefited from the program based on survey responses regarding attitudes toward medical physics and interest in learning more about medical physics.</p><p><strong>Discussion: </strong>This pilot study demonstrated the feasibility and effectiveness of an educational model for teachers' understanding and connecting medical physics with students in their schools.  The program was well received by teachers and students, and this manuscript provides guidelines for effective replication of the curriculum at other institutions.</p>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":" ","pages":"e70087"},"PeriodicalIF":2.0,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143779892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An extension to the OVH concept for knowledge-based dose volume histogram prediction in lung tumor volumetric-modulated arc therapy. 基于知识的剂量-体积直方图预测在肺肿瘤体积调节弧治疗中的OVH概念的扩展。
IF 2 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-03 DOI: 10.1002/acm2.70090
Johann Brand, Juliane Szkitsak, Oliver J Ott, Christoph Bert, Stefan Speer

Purpose: Volumetric-modulated arc therapy (VMAT) treatment planning allows a compromise between a sufficient coverage of the planning target volume (PTV) and a simultaneous sparing of organs-at-risk (OARs). Particularly in the case of lung tumors, deciding whether it is possible or worth spending more time on further improvements of a treatment plan is difficult. Therefore, this work aims to develop a knowledge-based, structure-dependent, automated dose volume histogram (DVH) prediction module for lung tumors.

Methods: The module is based on comparing geometric relationships between the PTV and the surrounding OARs. Therefore, treatment plan and structure data of 106 lung cancer cases, each treated in 28 fractions and 180 cGy/fx, were collected. To access the spatial information, a two-dimensional metric named overlap volume histogram (OVH) was used. Due to the rotational symmetry of the OVH and the typically coplanar setup of the VMAT technique, OVH is complemented by the so-called overlap-z-histogram (OZH). A set of achievable DVHs is predicted by identifying plans in the database with similar OVH and OZH. By splitting the dataset into a test set of 22 patients and a training set of 84 patients, the prediction capability of the OVH-OZH combination was evaluated. For comparison between the predicted and achieved DVH curves the coefficient of determination R2 was calculated.

Results: The total lung showed strong linearity between predicted and achieved DVH curves for the OVH-OZH combination, resulting in a R 2 ${R^2}$ value close to 1 (0.975 ± 0.022). The heart benefits the most of the OZH resulting in a high prediction capability, with a higher R 2 ${R^2}$ of 0.962 ± 0.036 compared to the prediction with OVH only (0.897 ± 0.087).

Conclusion: The combination of OZH and OVH was suitable for building a knowledge-based automated DVH prediction module. Implementing this method into the clinical workflow of treatment planning will contribute to advancing the quality of VMAT plans.

目的:容积调控弧形疗法(VMAT)治疗计划可以在充分覆盖计划靶体积(PTV)和同时保留危险器官(OAR)之间取得折中。特别是在肺部肿瘤的情况下,决定是否有可能或值得花更多时间进一步改进治疗计划是很困难的。因此,这项工作旨在开发一个基于知识、依赖结构的肺部肿瘤自动剂量体积直方图(DVH)预测模块:该模块基于比较 PTV 与周围 OAR 之间的几何关系。因此,收集了 106 个肺癌病例的治疗计划和结构数据,每个病例均接受了 28 次分次治疗和 180 cGy/fx。为了获取空间信息,我们使用了一种名为重叠容积直方图(OVH)的二维度量方法。由于 OVH 的旋转对称性和 VMAT 技术的典型共面设置,OVH 得到了所谓的重叠-z 直方图(OZH)的补充。通过识别数据库中具有相似 OVH 和 OZH 的计划,可以预测出一组可实现的 DVH。通过将数据集分成由 22 名患者组成的测试集和由 84 名患者组成的训练集,对 OVH-OZH 组合的预测能力进行了评估。为了比较预测的 DVH 曲线和实现的 DVH 曲线,计算了决定系数 R2:结果:OVH-OZH 组合的预测 DVH 曲线与实现的 DVH 曲线之间具有很强的线性关系,因此 R 2 ${R^2}$ 值接近 1 (0.975 ± 0.022)。心脏从 OZH 中获益最多,因此预测能力较高,与仅使用 OVH 的预测(0.897 ± 0.087)相比,R 2 ${R^2}$ 为 0.962 ± 0.036:结论:OZH 和 OVH 的结合适用于构建基于知识的 DVH 自动预测模块。将该方法应用于治疗计划的临床工作流程将有助于提高 VMAT 计划的质量。
{"title":"An extension to the OVH concept for knowledge-based dose volume histogram prediction in lung tumor volumetric-modulated arc therapy.","authors":"Johann Brand, Juliane Szkitsak, Oliver J Ott, Christoph Bert, Stefan Speer","doi":"10.1002/acm2.70090","DOIUrl":"https://doi.org/10.1002/acm2.70090","url":null,"abstract":"<p><strong>Purpose: </strong>Volumetric-modulated arc therapy (VMAT) treatment planning allows a compromise between a sufficient coverage of the planning target volume (PTV) and a simultaneous sparing of organs-at-risk (OARs). Particularly in the case of lung tumors, deciding whether it is possible or worth spending more time on further improvements of a treatment plan is difficult. Therefore, this work aims to develop a knowledge-based, structure-dependent, automated dose volume histogram (DVH) prediction module for lung tumors.</p><p><strong>Methods: </strong>The module is based on comparing geometric relationships between the PTV and the surrounding OARs. Therefore, treatment plan and structure data of 106 lung cancer cases, each treated in 28 fractions and 180 cGy/fx, were collected. To access the spatial information, a two-dimensional metric named overlap volume histogram (OVH) was used. Due to the rotational symmetry of the OVH and the typically coplanar setup of the VMAT technique, OVH is complemented by the so-called overlap-z-histogram (OZH). A set of achievable DVHs is predicted by identifying plans in the database with similar OVH and OZH. By splitting the dataset into a test set of 22 patients and a training set of 84 patients, the prediction capability of the OVH-OZH combination was evaluated. For comparison between the predicted and achieved DVH curves the coefficient of determination R<sup>2</sup> was calculated.</p><p><strong>Results: </strong>The total lung showed strong linearity between predicted and achieved DVH curves for the OVH-OZH combination, resulting in a <math> <semantics><msup><mi>R</mi> <mn>2</mn></msup> <annotation>${R^2}$</annotation></semantics> </math> value close to 1 (0.975 ± 0.022). The heart benefits the most of the OZH resulting in a high prediction capability, with a higher <math> <semantics><msup><mi>R</mi> <mn>2</mn></msup> <annotation>${R^2}$</annotation></semantics> </math> of 0.962 ± 0.036 compared to the prediction with OVH only (0.897 ± 0.087).</p><p><strong>Conclusion: </strong>The combination of OZH and OVH was suitable for building a knowledge-based automated DVH prediction module. Implementing this method into the clinical workflow of treatment planning will contribute to advancing the quality of VMAT plans.</p>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":" ","pages":"e70090"},"PeriodicalIF":2.0,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143779891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BreastWatch: A Varian Eclipse script tool for Community-Based automatic evaluation of breast treatment plans. BreastWatch:一个Varian Eclipse脚本工具,用于基于社区的乳房治疗计划的自动评估。
IF 2 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-01 DOI: 10.1002/acm2.70080
Stefano Agostinelli, Daniele Zefiro, Stefania Garelli, Francesca Cavagnetto, Marco Gusinu, Monica Bevegni, Gladys Blandino, Alessandra Fozza, Fabrizio Levrero

Purpose: This work introduces BreastWatch, a Varian Eclipse script tool designed to help medical physicists, dosimetrists, and radiation oncologists easily inspect and improve External Beam Breast Treatment (EBBT) plans using automatic evaluation of protocol dose-constraints enhanced by a Community-Based approach.

Methods: BreastWatch examines Eclipse EBBT Plans and Plan Sums, automatically testing the plan's DVH against built-in international EBBT protocol (NRG RTOG1005, ICR Fast-Forward, ICR FAST, and EUROPA 1.2) dose-constraints. Results are displayed using traffic lights and an overall BW-SCORE. To overcome protocol dose-constraints limitations, the script can export plan data and dose values in CSV format to build a Community-Based Plan Library. These data are automatically read back in BreastWatch to check plans against the statistical distribution of similar Community plans and compute a CB-SCORE, which complements the protocol-based BW-SCORE. In this paper, BreastWatch v.1.6.5.0 script's design and strengths are examined and discussed, after extensive testing with more than 800 EBBT plans by six experienced planners. In a preliminary analysis, the usefulness of the CB approach is investigated by examining the chronological series of two dose-constraints values (Contra-Lung V3Gy and Heart Average Dose) before and after its introduction in BreastWatch.

Results: We found BreastWatch to speed up the EBBT planning process, while at the same time helping to improve the treatment plans in terms of PTVs coverage and uniformity, sparing of OARs, consistency, and robustness among different planners. The preliminary analysis of the chronological series of two dose-constraints values for a subgroup of 68 EBBT plans shows a trend (p-value = 0.07) for values to be improved and more consistent after the CB approach introduction.

Conclusions: The BreastWatch script is a useful tool for the automatic evaluation of Eclipse EBBT plans. BreastWatch and its Community-Based features have been found to be a simple but effective automation approach to improve the EBBT planning process.

目的:本工作介绍了BreastWatch,这是一个Varian Eclipse脚本工具,旨在帮助医学物理学家、剂量测定师和放射肿瘤学家轻松检查和改进外束乳房治疗(EBBT)计划,使用基于社区的方法增强的方案剂量限制的自动评估。方法:BreastWatch检查Eclipse EBBT计划和计划总额,根据内置的国际EBBT协议(NRG RTOG1005, ICR FAST, ICR FAST和EUROPA 1.2)剂量限制自动测试计划的DVH。结果显示使用交通灯和整体BW-SCORE。为了克服方案剂量限制的限制,该脚本可以以CSV格式导出计划数据和剂量值,以构建基于社区的计划库。这些数据在BreastWatch中自动回读,以对照类似社区计划的统计分布检查计划,并计算CB-SCORE,这是对基于协议的BW-SCORE的补充。本文对BreastWatch v.1.6.5.0脚本的设计和优势进行了检查和讨论,经过六位经验丰富的规划师对800多个EBBT计划进行了广泛的测试。在初步分析中,通过检查在《BreastWatch》引入前后两个剂量限制值(对肺V3Gy和心脏平均剂量)的时间序列,对CB方法的有效性进行了调查。结果:我们发现BreastWatch加快了EBBT的计划过程,同时在不同计划者之间的ptv覆盖率和均匀性、节省桨叶、一致性和稳健性方面有助于改善治疗计划。对68个EBBT计划亚组的两个剂量限制值的时间序列进行的初步分析显示,在采用CB方法后,这些值有改善和更加一致的趋势(p值= 0.07)。结论:BreastWatch脚本对于Eclipse EBBT计划的自动评估是一个有用的工具。人们发现,“母乳观察”及其基于社区的功能是一种简单但有效的自动化方法,可以改善EBBT规划过程。
{"title":"BreastWatch: A Varian Eclipse script tool for Community-Based automatic evaluation of breast treatment plans.","authors":"Stefano Agostinelli, Daniele Zefiro, Stefania Garelli, Francesca Cavagnetto, Marco Gusinu, Monica Bevegni, Gladys Blandino, Alessandra Fozza, Fabrizio Levrero","doi":"10.1002/acm2.70080","DOIUrl":"https://doi.org/10.1002/acm2.70080","url":null,"abstract":"<p><strong>Purpose: </strong>This work introduces BreastWatch, a Varian Eclipse script tool designed to help medical physicists, dosimetrists, and radiation oncologists easily inspect and improve External Beam Breast Treatment (EBBT) plans using automatic evaluation of protocol dose-constraints enhanced by a Community-Based approach.</p><p><strong>Methods: </strong>BreastWatch examines Eclipse EBBT Plans and Plan Sums, automatically testing the plan's DVH against built-in international EBBT protocol (NRG RTOG1005, ICR Fast-Forward, ICR FAST, and EUROPA 1.2) dose-constraints. Results are displayed using traffic lights and an overall BW-SCORE. To overcome protocol dose-constraints limitations, the script can export plan data and dose values in CSV format to build a Community-Based Plan Library. These data are automatically read back in BreastWatch to check plans against the statistical distribution of similar Community plans and compute a CB-SCORE, which complements the protocol-based BW-SCORE. In this paper, BreastWatch v.1.6.5.0 script's design and strengths are examined and discussed, after extensive testing with more than 800 EBBT plans by six experienced planners. In a preliminary analysis, the usefulness of the CB approach is investigated by examining the chronological series of two dose-constraints values (Contra-Lung V3Gy and Heart Average Dose) before and after its introduction in BreastWatch.</p><p><strong>Results: </strong>We found BreastWatch to speed up the EBBT planning process, while at the same time helping to improve the treatment plans in terms of PTVs coverage and uniformity, sparing of OARs, consistency, and robustness among different planners. The preliminary analysis of the chronological series of two dose-constraints values for a subgroup of 68 EBBT plans shows a trend (p-value = 0.07) for values to be improved and more consistent after the CB approach introduction.</p><p><strong>Conclusions: </strong>The BreastWatch script is a useful tool for the automatic evaluation of Eclipse EBBT plans. BreastWatch and its Community-Based features have been found to be a simple but effective automation approach to improve the EBBT planning process.</p>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":" ","pages":"e70080"},"PeriodicalIF":2.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143763845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toward a human-centric co-design methodology for AI detection of differences between planned and delivered dose in radiotherapy. 以人为中心的协同设计方法,用于人工智能检测放射治疗中计划剂量和交付剂量之间的差异。
IF 2 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-03-31 DOI: 10.1002/acm2.70071
Luca M Heising, Frank Verhaegen, Stefan G Scheib, Maria J G Jacobs, Carol X J Ou, Viola Mottarella, Yin-Ho Chong, Mariangela Zamburlini, Sebastiaan M J J G Nijsten, Ans Swinnen, Michel Öllers, Cecile J A Wolfs

Introduction: Many artificial intelligence (AI) solutions have been proposed to enhance the radiotherapy (RT) workflow, but limited applications have been implemented to date, suggesting an implementation gap. One contributing factor to this gap is a misalignment between AI systems and their users. To address the AI implementation gap, we propose a human-centric methodology, novel in RT, for an interface design of an AI-driven RT treatment error detection system.

Methods: A 5-day design sprint was set up with a multi-disciplinary team of clinical and research staff and a commercial company. In the design sprint, an interface was prototyped to aid medical physicists in catching treatment errors during daily treatment fractions using dose-guided RT (DGRT) with a portal imager.

Results: The design sprint resulted in a simulated prototype of an interface supported by all stakeholders. Important features of an interface include the AI certainty metric, explainable AI features, feedback options, and decision aid. The prototype was well-received by expert users.

Conclusion/discussion: Using a co-creation strategy, which is a novel approach in RT, we were able to prototype a novel human-interpretable interface to detect RT treatment errors and aid the DGRT workflow. Users showed confidence that the overall design method and the proposed prototype could lead to a viable clinical implementation.

已经提出了许多人工智能(AI)解决方案来增强放射治疗(RT)工作流程,但迄今为止实施的应用有限,表明实施差距。造成这种差距的一个因素是人工智能系统与其用户之间的不一致。为了解决人工智能实现的差距,我们提出了一种在人工智能驱动的人工智能治疗错误检测系统的界面设计中以人为中心的方法,这在人工智能中是新颖的。方法:由临床和研究人员组成的多学科团队与一家商业公司建立为期5天的设计冲刺。在设计冲刺中,设计了一个界面原型,以帮助医学物理学家使用带有传送门成像仪的剂量引导RT (DGRT)捕捉日常治疗过程中的治疗错误。结果:设计冲刺产生了所有利益相关者支持的界面模拟原型。界面的重要功能包括AI确定性度量、可解释的AI功能、反馈选项和决策辅助。原型机受到了专家用户的好评。结论/讨论:使用共同创建策略,这是RT中的一种新方法,我们能够原型化一种新的人类可解释界面,以检测RT治疗错误并帮助DGRT工作流程。用户对整体设计方法和提出的原型可以导致可行的临床实施表现出信心。
{"title":"Toward a human-centric co-design methodology for AI detection of differences between planned and delivered dose in radiotherapy.","authors":"Luca M Heising, Frank Verhaegen, Stefan G Scheib, Maria J G Jacobs, Carol X J Ou, Viola Mottarella, Yin-Ho Chong, Mariangela Zamburlini, Sebastiaan M J J G Nijsten, Ans Swinnen, Michel Öllers, Cecile J A Wolfs","doi":"10.1002/acm2.70071","DOIUrl":"https://doi.org/10.1002/acm2.70071","url":null,"abstract":"<p><strong>Introduction: </strong>Many artificial intelligence (AI) solutions have been proposed to enhance the radiotherapy (RT) workflow, but limited applications have been implemented to date, suggesting an implementation gap. One contributing factor to this gap is a misalignment between AI systems and their users. To address the AI implementation gap, we propose a human-centric methodology, novel in RT, for an interface design of an AI-driven RT treatment error detection system.</p><p><strong>Methods: </strong>A 5-day design sprint was set up with a multi-disciplinary team of clinical and research staff and a commercial company. In the design sprint, an interface was prototyped to aid medical physicists in catching treatment errors during daily treatment fractions using dose-guided RT (DGRT) with a portal imager.</p><p><strong>Results: </strong>The design sprint resulted in a simulated prototype of an interface supported by all stakeholders. Important features of an interface include the AI certainty metric, explainable AI features, feedback options, and decision aid. The prototype was well-received by expert users.</p><p><strong>Conclusion/discussion: </strong>Using a co-creation strategy, which is a novel approach in RT, we were able to prototype a novel human-interpretable interface to detect RT treatment errors and aid the DGRT workflow. Users showed confidence that the overall design method and the proposed prototype could lead to a viable clinical implementation.</p>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":" ","pages":"e70071"},"PeriodicalIF":2.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143752739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vivo transit dosimetry methodology for whole breast intensity modulated radiation therapy. 全乳强度调制放射治疗的体内传输剂量法。
IF 2 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-03-26 DOI: 10.1002/acm2.70072
Lucia Zirone, Elisa Bonanno, Giuseppina R Borzì, Nina Cavalli, Alessia D'Anna, Andrea Girlando, Martina Pace, Giuseppe Stella, Carmelo Marino

Background: In vivo transit dosimetry using an electronic portal imaging device (EPID-IVTD) is an important tool for verifying the accuracy of radiation therapy treatments. Despite its potential, the implementation of EPID-IVTD in breast intensity modulated radiation therapy (IMRT) treatments has not yet been standardized, limiting its clinical adoption. A standardized EPID-IVTD method could enhance treatment accuracy and improve patient safety in routine clinical practice.

Purpose: This study aims to develop a method for EPID-IVTD for whole breast IMRT treatment.

Methods: Gamma passing rates (GPRs) analysis was the basis of the work conducted on a dataset of 50 patients. The first phase of the work focused on the identification of the reference fraction. In the second phase a method for performing EPID-IVTD was implemented. Lower-tolerance and -action limits (l-TL and l-AL), as introduced by AAPM TG 218, were employed to determine the reference fraction and used as alert and alarm thresholds, respectively, in EPID-IVTD monitoring.

Results: The first treatment fraction demonstrated the best dosimetric agreement with the theoretical plan and was therefore used as the reference in the second phase of the study. EPID-IVTD results showed that 75% of the GPRs ranged from 97.5% to 99.9%, 93.83% were above the l-TL, 4.31% fell between l-TL and l-AL, and 1.86% were below l-AL.

Conclusions: A method for the implementation of an effective EPID-IVTD in whole breast IMRT treatment was developed and is now routinely applied at our center, enabling efficient monitoring in clinical practice.

背景:使用电子门静脉成像装置(EPID-IVTD)进行体内传输剂量测定是验证放射治疗准确性的重要工具。尽管具有潜力,EPID-IVTD在乳房强度调节放疗(IMRT)治疗中的实施尚未标准化,限制了其临床应用。标准化的EPID-IVTD方法可以提高常规临床治疗的准确性,提高患者的安全性。目的:研究EPID-IVTD在全乳IMRT治疗中的应用。方法:Gamma通过率(GPRs)分析是对50例患者数据集进行工作的基础。第一阶段的工作重点是鉴定参考分数。在第二阶段,实现了执行EPID-IVTD的方法。采用AAPM TG 218引入的低耐受限值和低作用限值(l-TL和l-AL)来确定参考分数,并分别作为EPID-IVTD监测的警报和报警阈值。结果:第一个处理分数与理论计划的剂量学一致性最好,因此被用作第二阶段研究的参考。EPID-IVTD结果显示,75%的gpr在97.5% ~ 99.9%之间,93.83%的gpr高于l-TL, 4.31%介于l-TL和l-AL之间,1.86%低于l-AL。结论:我们开发了一种在全乳IMRT治疗中实施EPID-IVTD的有效方法,目前已在我中心常规应用,可在临床实践中进行有效的监测。
{"title":"In vivo transit dosimetry methodology for whole breast intensity modulated radiation therapy.","authors":"Lucia Zirone, Elisa Bonanno, Giuseppina R Borzì, Nina Cavalli, Alessia D'Anna, Andrea Girlando, Martina Pace, Giuseppe Stella, Carmelo Marino","doi":"10.1002/acm2.70072","DOIUrl":"https://doi.org/10.1002/acm2.70072","url":null,"abstract":"<p><strong>Background: </strong>In vivo transit dosimetry using an electronic portal imaging device (EPID-IVTD) is an important tool for verifying the accuracy of radiation therapy treatments. Despite its potential, the implementation of EPID-IVTD in breast intensity modulated radiation therapy (IMRT) treatments has not yet been standardized, limiting its clinical adoption. A standardized EPID-IVTD method could enhance treatment accuracy and improve patient safety in routine clinical practice.</p><p><strong>Purpose: </strong>This study aims to develop a method for EPID-IVTD for whole breast IMRT treatment.</p><p><strong>Methods: </strong>Gamma passing rates (GPRs) analysis was the basis of the work conducted on a dataset of 50 patients. The first phase of the work focused on the identification of the reference fraction. In the second phase a method for performing EPID-IVTD was implemented. Lower-tolerance and -action limits (l-TL and l-AL), as introduced by AAPM TG 218, were employed to determine the reference fraction and used as alert and alarm thresholds, respectively, in EPID-IVTD monitoring.</p><p><strong>Results: </strong>The first treatment fraction demonstrated the best dosimetric agreement with the theoretical plan and was therefore used as the reference in the second phase of the study. EPID-IVTD results showed that 75% of the GPRs ranged from 97.5% to 99.9%, 93.83% were above the l-TL, 4.31% fell between l-TL and l-AL, and 1.86% were below l-AL.</p><p><strong>Conclusions: </strong>A method for the implementation of an effective EPID-IVTD in whole breast IMRT treatment was developed and is now routinely applied at our center, enabling efficient monitoring in clinical practice.</p>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":" ","pages":"e70072"},"PeriodicalIF":2.0,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143709594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Applied Clinical Medical Physics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1